–
Mereo BioPharma Group plc
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−54.4
FY23:
−28.4
FY24:
−47.4
FY25:
−40.1
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−42.9
FY23:
−30.0
FY24:
−43.3
FY25:
−41.9
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−42.2
FY23:
−29.5
FY24:
−43.3
FY25:
−41.9
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.